Project Grant R61DA064828
Award Date 3/15/26
Completion Date 2/29/28
Dollars Obligated $454K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10017, USA
Similar Awards
- Federal Grant Award Summary Award Details: Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Award Amount: $193,752 Award Date: April 15, 2025 Project Period: April 15, 2025 – March 31, 2030 Recipient: Boston Medical Center Corporation Products and Services: This K23 Career Development Award supports research and implementation activities focused on promoting positive parenting outcomes for mothers with Opioid...
- Federal Grant Award Summary Chestnut Health Systems Inc. received a $796,786 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 1, 2025 through July 31, 2027. This R61/R33 phased award, submitted in response to RFA-DA-24-066 as part of the Helping to End Addiction Long-term (HEAL) Initiative, supports the development and testing of BUILD IT (Building for Implementation Tool), a digital...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded McLean Hospital a $453,654 Project Grant on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support the Recovery Inspired Support Engagement (RISE) initiative. The grant funds research and intervention development targeting support persons (family members, friends, and other social connections) of individuals with substance use disorders, with a particular focus on critical...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a novel precision medicine tool addressing the opioid epidemic. The platform leverages generative artificial intelligence, machine learning algorithms, and biometric data analytics from wrist wearables to...
- Federal Grant Award Summary Callentis Consulting Group LLC, a woman-owned small business based in Austin, Texas, received a $795,658 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 1, 2025, with completion targeted for April 30, 2027. The award supports the development of an artificial intelligence (AI)-based platform designed to accelerate the discovery of therapeutics for substance use disorders (SUDs),...
- Federal Project Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025 and concluding August 31, 2026. The award funds the development and refinement of an adaptable medication adherence and monitoring system specifically designed to support decentralized clinical trials (DCTs) for substance use disorder (SUD) treatment. The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Pittsburgh a $188,307 Project Grant, effective September 1, 2025, through August 31, 2029, under the Drug Use and Addiction Research Programs (CFDA 93.279). Led by Principal Investigator Dr. Edwards, this initiative will develop a guided, web-based behavioral treatment intervention combining Acceptance and Commitment Therapy (ACT) for chronic pain and Mindfulness-Based Relapse Prevention (MBRP)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital $395,280 under the Drug Use and Addiction Research Programs (CFDA 93.279) Project Grant mechanism on July 1, 2025, for a five-year project period concluding June 30, 2030. The award supports the development and pilot testing of AMP-C, a digital therapeutic (DTX) designed to address reward dysfunction in individuals with co-occurring Cannabis Use Disorder (CUD) and Major Depressive...